Document Type
Article
Publication Date
5-8-2025
Publication Title
JAAD Reviews
Abstract
Patients with visible skin diseases, including acne, psoriasis, and atopic dermatitis, face heightened risks of psychological distress, depression, and suicidal ideation, often exacerbated by social stigma and reduced quality of life. This review explores the intersection between dermatology and suicide, highlighting the psychosocial impact of visible skin conditions and the controversies surrounding treatment-related risks, including isotretinoin and biologic exposure. Current evidence suggests that while isotretinoin has been historically linked to mood changes, robust studies do not support a direct association with suicide. Incorporating mental health screenings into dermatological practice is essential for early identification and management of at-risk patients. By fostering collaboration between dermatologists and mental health professionals and by implementing targeted management strategies, dermatologic care can comprehensively address both physical and psychological well-being, mitigating suicide risks and improving patient outcomes.
First Page
195
Last Page
202
Volume
4
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
Islam, Rahib K.; Tong, Victoria T.; and Lipner, Shari R., "A clinical review of suicide risks in dermatology" (2025). School of Medicine Faculty Publications. 4306.
https://digitalscholar.lsuhsc.edu/som_facpubs/4306
10.1016/j.jdrv.2025.02.007
Included in
Behavior and Behavior Mechanisms Commons, Dermatology Commons, Medicine and Health Commons, Skin and Connective Tissue Diseases Commons, Therapeutics Commons